This is the website for the British Association of Dermatologists Biologic Interventions Register. BADBIR is an UK and Eire observational study which seeks to assess the long-term safety of biologic treatments for psoriasis. The National Institute for Health and Clinical Excellence (NICE) has recommended that all patients in the UK receiving these new therapies for psoriasis should be registered with us.
There are currently over 140 hospital sites across the UK and Eire taking part in BADBIR by recruiting participants to join the Register. Once a patient has joined BADBIR, they are followed via their dermatologist until 2018 as we assess their clinical details. More information on BADBIR can be found in both the Participants and Clinicians sections of the website.
BADBIR is based at the University of Manchester and is part of the Arthritis Research UK Epidemiology Unit. Should you ever have any queries on any aspect of the Register please get in touch via email or on 0161 306 1896.